In a report published Thursday, Goldman Sachs analyst Isaac Ro upgraded the rating on Thermo Fisher Scientific TMO from Neutral to Buy, and raised the price target from $114.00 to $153.00.
In the report, Goldman Sachs noted, “We upgrade shares of Thermo Fisher Scientific (TMO) to Buy from Neutral with 24% upside to our new $153 12-month price target. Although TMO shares have outperformed over the past 12 months (+4,500bps vs. S&P 500 and +3,100bps vs. XLV), we think consensus still underappreciates Thermo's long-term growth profile and potential for continued multiple expansion.”
Thermo Fisher Scientific closed on Wednesday at $121.81.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in